The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Ginkgo biloba for cerebral insufficiency.
Open accessAbstract
1. By means of a critical review we tried to establish whether there is evidence from controlled trials in humans on the efficacy of Ginkgo biloba extracts in cerebral insufficiency. 2. The methodological quality of 40 trials on Ginkgo and cerebral insufficiency was assessed using a list of predefined criteria of good methodology, and the outcome of the trials was interpreted in relation to their quality. A comparison of the quality was made with trials of co‐dergocrine, which is registered for the same indication. 3. There were eight well performed trials out of a total of 40. Shortcomings were limited numbers of patients included, and incomplete description of randomization procedures, patient characteristics, effect measurement and data presentation. In no trial was double‐blindness checked. Virtually all trials reported positive results, in most trials the dosage was 120 mg Ginkgo extract a day, given for at least 4‐6 weeks. For the best trials, there were no marked differences in the quality of the evidence of the efficacy of Ginkgo in cerebral insufficiency compared with co‐dergocrine. The results of the review may be complicated by a combination of publication bias and other biases, because there were no negative results reported in many trials of low methodological quality. 4. Positive results have been reported for Ginkgo biloba extracts in the treatment of cerebral insufficiency. The clinical evidence is similar to that of a registered product which is prescribed for the same indication. However, further studies should be conducted for a more detailed assessment of the efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical trials of homoeopathy.
Kleijnen, J., Knipschild, P., & ter Riet, G. (1991) · BMJ · doi:10.1136/bmj.302.6772.316 · Cited by 604
Self-citationEmerson, J. D., Burdick, E., Hoaglin, D. C., Mosteller, F., & Chalmers, T. C. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90175-2 · Cited by 241
Rai, G. S., Shovlin, C. L., & Wesnes, K. A. (1991) · Current Medical Research and Opinion · doi:10.1185/03007999109111504 · Cited by 157
Preparation and Definition of Ginkgo Biloba Extract
Drieu, K. (1988) · Springer eBooks · doi:10.1007/978-3-642-73686-5_3 · Cited by 139
Wesnes, K. A., Simmons, D., Rook, M., & Simpson, P. (1987) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470020305 · Cited by 101
The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers.
Subhan, Z., & Hindmarch, I. (1984) · PubMed · Cited by 71
Gessner, B., Voelp, A., & Klasser, M. (1985) · PubMed · Cited by 56
Meyer, B. (1986) · PubMed · Cited by 44
Kleijnen, J., Knipschild, P. G., & ter Riet, G. (1991) · BMJ · doi:10.1136/bmj.302.6782.960 · Cited by 31
Self-citation
Cited by
Health-promoting properties of common herbs
Craig, W. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.491s · Cited by 1,095
Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., & Bickford, P. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08114.1999 · Cited by 980
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease
Oken, B. S., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Metadata
- Authors
- Kleijnen, J., & Knipschild, P.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1992-10
- Volume
- 34
- Issue
- 4
- Pages
- 352-358
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2024311146
- Cited by
- 338
- References
- 18
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ginkgo biloba for cerebral insufficiency. https://app.cochat.ai/papers/10.1111/j.1365-2125.1992.tb05642.x
- The paper
- Kleijnen, J., & Knipschild, P. (1992). Ginkgo biloba for cerebral insufficiency. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1992.tb05642.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.